A Comparison of Continuation Rates for Three Hormonal Contraceptive Methods

Completed

• Conditions: Contraception

• Registration Number: NCT00253019
• Lead Sponsor: Emory University

Brief Summary

This study will assess the continuation rates among women using oral contraceptive pills, Depo-Provera and Ortho Evra following a first trimester abortion.

Detailed Description

Unintended pregnancy rates among women in the United States continue to surpass that of the rest of the developed world at great cost to society. Contraceptive failure has been attributed to poor compliance with contraceptive methods and results in unintended pregnancies. This study will evaluate the 3-month continuation rates among women using the oral contraceptive pill and Depo-Provera. It will also assess the continuation rates of Ortho Evra®, which has not previously been studied in the adolescent population. This study will provide information with regard to pregnancy rates and 3-month patterns of use of contraception among women seeking first-trimester abortion. It will also assess other factors contributing to successful contraception such as the use of emergency contraception and concomitant condom use. The results of this study will be used to inform the practice of providers who provide reproductive health care to women and add to the sparse body of literature available comparing the success of different contraceptive methods used by women.

Study Timeline

• Study Start: 2004-10
• Primary Completion: 2005-11
• Study Completion: 2005-11
• Study First Submitted: 2005-11-14
• Study First Submitted QC: 2005-11-14
• Study First Posted: 2005-11-15
• Results First Submitted: 2013-04-09
• Results First Submitted QC: 2013-07-09
• Status Verified: 2013-08
• Results First Posted: 2013-08-09
• Last Update Submitted: 2013-08-10
• Last Update Posted: 2013-08-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 321

Inclusion Criteria

• Age 13-45 women presenting at the ambulatory surgery at Grady Memorial Hospital who want to use either oral contraceptive pills, ortho evra or depo provera?

Exclusion Criteria

• Leaving the Atlanta area within 6 months?
• Desires pregnancy within the next 6 months?
• Unable to provide contact information?
• Contraindications to hormonal contraceptive?

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Continuation Rates	3 months	We followed subjects to evaluate the continuation rates for subjects receiving oral contraceptive pills, Depo Provera and Ortho Evra.

Trial Locations

Locations (1)

Grady Memorial Hospital; 🇺🇸 Atlanta, Georgia, United States